Pitcairn Co
- SEC CIK
- 0000315014
- Latest filing
- Aug 10, 2026
TXG holding history
10x Genomics, Inc. in every 13F filed by Pitcairn Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXG overviewAll 13F holders of TXGFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −5,648−100.0% | Sold out | Holders |
| Q1 2024 | 5,648 | $212.0K | <0.1% | −1,259−18.2% | Reduced | Holders |
| Q4 2023 | 6,907 | $386.5K | <0.1% | −656−8.7% | Reduced | Holders |
| Q3 2023 | 7,563 | $312.0K | <0.1% | −1,318−14.8% | Reduced | Holders |
| Q2 2023 | 8,881 | $495.9K | <0.1% | +1,342+17.8% | Added | Holders |
| Q1 2023 | 7,539 | $420.6K | <0.1% | +1,898+33.6% | Added | Holders |
| Q4 2022 | 5,641 | $205.6K | <0.1% | +5,641 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −5,507−100.0% | Sold out | Holders |
| Q2 2022 | 5,507 | $249.0K | <0.1% | +1,653+42.9% | Added | Holders |
| Q1 2022 | 3,854 | $293.0K | <0.1% | +2,480+180.5% | Added | Holders |
| Q4 2021 | 1,374 | $205.0K | <0.1% | +1,374 | New | Holders |